Results

Looking for more? ProQuest® Dissertations & Theses has additional dissertations and theses.
257 open access dissertations and theses found for:
if(HER2)  »   Refine Search
1.
Human Serum Albumin and Affibody Fusion Proteins for Targeted Drug Delivery to HER2 Positive Cells
by Dong, Daoyuan, Ph.D.  University of the Sciences in Philadelphia. 2017: 128 pages; 10629208.
3.
Characterization of the Natural Killer Cell Cytokine Response to Antibody-Coated Tumor Cells
by Parihar, Robin, Ph.D.  The Ohio State University. 2004: 230 pages; 10834922.
4.
The role of nuclear receptor coactivator AIB1/SRC3 in normal and breast cancer stromal functions
by Al-Otaiby, Maram Abdulmohsen, Ph.D.  Georgetown University. 2012: 166 pages; 3505253.
5.
Optical contrast agents to visualize molecular expression in breast cancer
by Langsner, Robert James, Ph.D.  Rice University. 2013: 226 pages; 3577602.
6.
Profiling flavonoid cytotoxicity in human breast cancer cell lines
by Yadegarynia, Sina, M.S.  San Jose State University. 2012: 92 pages; 1533049.
7.
Clinical implementation of breast cancer genomics
by Parker, Joel Stanley, Ph.D.  The University of North Carolina at Chapel Hill. 2010: 131 pages; 3428393.
8.
Chip-Scale Fluorescence Microscope
by Papageorgiou, Efthymios Philip, Ph.D.  University of California, Berkeley. 2019: 84 pages; 13883892.
9.
High level integration of genomic data for improving prediction, prognostication and classification of breast tumors
by Weigman, Victor John, Jr., Ph.D.  The University of North Carolina at Chapel Hill. 2010: 173 pages; 3428408.
10.
The synergistic effect of anti-androgens and signal transduction inhibitors in prostate cancer progression
by Schayowitz, Adam B., Ph.D.  University of Maryland, Baltimore. 2008: 186 pages; 3304002.
11.
CAPER as a Therapeutic Target for Triple Negative Breast Cancer
by Campbell, Mallory Christine, Ph.D.  University of the Sciences in Philadelphia. 2018: 123 pages; 10904829.
12.
Rethinking platinum anticancer drug design: Towards targeted and immuno-chemotherapeutic approaches
by Qiang, Daniel Wong Yuan, Ph.D.  National University of Singapore (Singapore). 2015: 241 pages; 10006102.
13.
Phosphorylated STAT3 (Tyr705) as a Biomarker of Response to Pimozide Treatment in Triple Negative Breast Cancer
by Dees, Sundee, Ph.D.  University of the Sciences in Philadelphia. 2020: 128 pages; 27671415.
14.
Tumor gangliosides, and tumor cell proliferation and signaling
by Nusinovich, Yevgeniya, Ph.D.  The George Washington University. 2007: 188 pages; 3288944.
15.
Development of CAPER Peptides for the Treatment of Breast Cancer
by Chilewski, Shannon D., Ph.D.  University of the Sciences in Philadelphia. 2020: 143 pages; 27547515.
16.
Deriving Novel Insights from Genomic Heterogeneity in Cancer
by Pique, Daniel Gonzalo, Ph.D.  Yeshiva University. 2018: 300 pages; 11014739.
17.
The Role of MicroRNA-155 in Human Breast Cancer
by Kong, William, Ph.D.  University of South Florida. 2010: 154 pages; 3432502.
18.
Examination of the BRCA1-dependent DNA repair pathway in basal-like breast cancers
by Chao, Hann-Hsiang, Ph.D.  The University of North Carolina at Chapel Hill. 2012: 196 pages; 3512604.
19.
ADAM9 metalloproteases and breast cancer cell migration
by Fry, Jessica Lynn, Ph.D.  Harvard University. 2010: 177 pages; 3395426.
20.
Overexpression of nSMase2 in 4T1 and E0771 Breast Cancer Cells Confers Varying Oncogenic Properties
by Miranda, Ian, M.S.  State University of New York at Stony Brook. 2019: 44 pages; 22619955.
21.
Evaluation of Inhibiting FECH and ABCG2 for Therapeutic Enhancement of ALA-PPIX Fluorescence and PDT
by Palasuberniam, Pratheeba, Ph.D.  University of the Sciences in Philadelphia. 2018: 139 pages; 10904837.
22.
Structure/function analysis of ErbB2
by Lucs, Alexandra Vitko, Ph.D.  State University of New York at Stony Brook. 2009: 105 pages; 3406704.
23.
Tumor versus matched-normal sequencing analysis and data integration
by Sanborn, J. Zachary, Ph.D.  University of California, Santa Cruz. 2012: 155 pages; 3551072.
24.
EGFR Rearrangements as Oncogenic Drivers and Therapeutic Targets in Lung Cancer
by Gallant, Jean-Nicolas, Ph.D.  Vanderbilt University. 2017: 127 pages; 10753387.
26.
Microfluidic Bioanalytical Device and Assay Development for High-Throughput Electrophoretic Protein Analysis
by Duncombe, Todd Andrew, D.Eng.  University of California, Berkeley. 2015: 138 pages; 10186639.
29.
The Paracaspase MALT1 is a Critical Mediator of PAR1-Driven NF-κB Activation and Tumor Metastasis
by McAuley, James Randall, Ph.D.  University of Pittsburgh. 2017: 113 pages; 10692563.
30.
Cancer Bioinformatics for Biomarker Discovery
by Webber, James Trubek, Ph.D.  University of California, San Francisco. 2017: 316 pages; 10604636.
1 - 30 of 257 displayed.
  1    2    3    4    5    6    7    8    9   Next >
Copyright © 2020 ProQuest LLC. All rights reserved. Terms and Conditions Privacy Policy Cookie Policy
ProQuest